Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 5/20 | 0.57 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.57 |
| ▸ | JAK3 | P52333 | 5/20 | 0.57 |
| ▸ | ROCK1 | Q13464 | 5/20 | 0.57 |
| ▸ | IKBKB | O14920 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | CASP6 | P55212 | 1/20 | 0.51 |
| ▸ | JAK1 | P23458 | 1/20 | 0.51 |
| ▸ | TYK2 | P29597 | 1/20 | 0.51 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14124389 | 0.94 | JAK2 (0.62) | JAK2ROCK2JAK3ROCK1IKBKB | |
| SCHEMBL14124391 | 0.84 | LMNA (0.63) | JAK2ROCK2JAK3ROCK1IKBKB | |
| SCHEMBL19860082 | 0.81 | ROCK1 (0.60) | ROCK2ROCK1PRMT3LMNA | |
| SCHEMBL2164137 | 0.81 | PRMT3 (0.69) | ROCK2ROCK1PRMT3LMNAMAPT | |
| SCHEMBL14124387 | 0.81 | IKBKB (0.57) | JAK2ROCK2JAK3ROCK1IKBKB | |
| SCHEMBL3566775 | 0.81 | PRMT3 (0.72) | ROCK2ROCK1PRMT3LMNAMAPT | |
| SCHEMBL19860083 | 0.78 | PRMT3 (0.53) | ROCK2ROCK1KMT2AMEN1PRMT3 | |
| SCHEMBL22752164 | 0.76 | JAK2 (0.89) | JAK2ROCK2JAK3ROCK1IKBKB | |
| SCHEMBL22752165 | 0.76 | JAK2 (0.89) | JAK2ROCK2JAK3ROCK1IKBKB | |
| SCHEMBL14124401 | 0.75 | IMPDH2 (0.61) | ROCK2KMT2AMEN1ALDH1A1PRMT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455513-B2 | Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide | AERIE PHARMACEUTICALS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-8455513-B2 | Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide | AERIE PHARMACEUTICALS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-20080167340-A1 | 6-Aminoisoquinoline Compounds | AERIE PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167340-A1 | 6-Aminoisoquinoline Compounds | AERIE PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167340-A1 | 6-Aminoisoquinoline Compounds | COQ8A, PGC, AGK | JAK2 616/4885ROCK2 246/4885JAK3 1217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.